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ABSTRACT 
The objective of this study was to prepare and evaluate sodium alginate microbeads with calcium chloride as cross-linking agent for Clonidine 
hydrochloride by ionotropic gelation method. Clonidine hydrochloride a centrally acting sympatholytic and imidazoline-derivative hypotensive 
agent; selective α2-adrenergic agonist. It stimulates alpha2-adrenergic receptors in the brainstem to decrease sympathetic nervous system 
outflow. It is also administered epidurally to treat pain. Microbeads offer numerous advantages for releasing one of the drugs or part of the same 
drug immediately while remaining drug or parts of the same can be sustained release. Prepared microbeads were evaluated for particle size, 
polydispersity index, zeta potential, particle shape, surface morphology, entrapment efficiency and In vitro drug release. The prepared beads 
were free flowing and white in color. The drug loaded beads showed 72.9±2.4% to 94.6±2.6 % drug entrapment, which was found to increase 
with increase in alginate concentration. In vitro drug release study of these microbeads indicated controlled release for Clonidine hydrochloride 
83.46% release after 48 hours. Hence the observations of all results of the different batches, MBD 11 showed controlled release action and 
improved drug availability. From this study it could be concluded that the free flowing microbeads of Clonidine hydrochloride could be 
successfully prepared by ionotropic gelation technique with high entrapment efficiency and prolonged release characteristics. 
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INTRODUCTION 
Controlled drug delivery technique presents front line part 
of today's developed technique, in this includes many 
scientific approaches, serving for individual care1. The drug 
deliverance technique having abundant advantages than 
existing conventional type of dosage, it involves enhanced 
effectiveness, minimized poisoning, enhanced consumer 
conformity also ease2, 3. This type of drug deliverance 
technique utilizes micro molecules, for caring drugs. As the 
varieties of forms for dosage are invented like microparticle 
as well as nanoparticles shown more significance 4, 5. An ideal 
and advanced oral drug delivery system is that, which 
exactly controls speed, time as well as site of release of 
medicament separately of normal physiological variables 
such as gastrointestinal tract pH, digestive condition of the 
gastrointestinal tract, peristalsis movement and circadian 
rhythm. Advance in polymer science and technology 
outcome in pick up the pace research and developmental 
activity in the design of drug delivery devices 6, 7. Clonidine 
hydrochloride a centrally acting sympatholytic and 
imidazoline-derivative hypotensive agent; selective α2-
adrenergic agonist. It stimulates alpha2-adrenergic 
receptors in the brainstem to decrease sympathetic nervous 
system outflow 8. It is also administered epidurally to treat 
pain. It is prescribed alone or in combination for the 
reduction of high blood pressure and is an adjunct for the 
treatment of cancer pain when pain persists during 
intraspinal opiate treatments9. It act by stimulating alpha-
adrenergic receptors in CNS, decreasing sympathetic 
outflow, inhibiting vasoconstriction, and ultimately reducing 
blood pressure. Also prevents transmission of pain impulses 
by inhibiting pain pathway signals in brain 10. The aim of the 
present study, which was to develop sustained release oral 
product namely microbeads of Clonidine hydrochloride 
using sodium alginate as the hydrophilic carrier in 
combination with calcium chloride as drug release modifiers 
in various proportions to overcome the drug related adverse 
effects, improve drug bioavailability. 
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MATERIAL AND METHOD 
Material 
Clonidine was received as a gift sample from Kalindi 
Medicure Pvt. Ltd, Vapi (India). Sodium alginate (Himedia 
chemicals, Mumbai), Calcium chloride (Unichem chemicals, 
Mumbai), All other reagents and chemicals used were of 
analytical grade. Triple distilled water was generated in 
house. 
Methods 
Method of Preparation of Microbeads   
The microbeads were prepared by ionotropic gelation 
technique in which sodium alginate (1-4%w/v) was 
accurately weighed and dissolved in slightly warmed 
distilled water. The sodium alginate solution was 
homogenized by stirring on magnetic stirrer for 45 min 
before formulation. Drug (10-40 %w/v) was accurately 
weighed and added or disperses in alginate solution during 
homoginaization.  After complete the homogenization 
process, solution was kept stand for 15 min without stirring 
and then sonicate for 10 min using bath sonicator to remove 
the air bubbles formed during homoginization.  In another 
beaker 100 ml of 3-6 % w/v calcium chloride solution was 
prepared in which sodium alginate solution containing drug 
was dropped with the help of 29 gauge hypodermic needle 
fitted with a 10ml syringe into previously prepared calcium 
chloride solution. 10 cm distance was maintained during 
dropping the alginates solution. Beads were incubated for 30 
min and after complete incubation beads were separated by 
filtering the solution. Obtained beads were washed three 
times with distilled water and dried at 40 ᵒC. Prepared beads 
were stored in very tight container before further use in 
their characterization11-13.  
Optimization of Drug Loaded Microbeads   
Optimization of polymer concentration  
Optimization of polymer in the microbeads formulation was 
carried by taking different concentration of polymer and 
other parameter was remaining constant. Microbeads were 
optimized on the basis of average particle size and drug 
entrapment. The stirring speed was kept remain constant i.e. 
400-500 rpm. 
  
Table 1: Optimization of polymer in the microbeads formulation 
Formulation 
Code 
Sodium Alginate 
(%w/v) 
Calcium Chloride 
(%) 
Drug Particle size 
(µm) 
Drug 
Entrapment 
MBD 1 1 3 10 156.7±2.30 72.9±2.4 
MBD 2 2 3 10 159.4±4.25 76.5±1.9 
MBD 3 3 3 10 173.4±3.7 82.2±2.4 
MBD 4 4 3 10 215.3±5.8 83.8±2.3 
   (n=3)  
Optimization of Calcium chloride concentration  
Calcium chloride worked as gelling agent by ionic interaction 
mechanism. It stabilize the polymer droplets so it is 
necessary to optimize the calcium chloride concentration to 
get a high stable microbeads formulation. Concentration of 
Calcium chloride was optimized for microbeads formulation 
by taking different concentration of calcium chloride and 
other parameter was kept constant. Microbeads were 
optimized on the basis of average particle size and drug 
entrapment and their shape and surface morphology. 
  
Table 2: Optimization of calcium chloride in the microbeads formulation 
Formulation 
Code 
Sodium 
Alginate 
(%w/v) 
Calcium 
Chloride 
(%w/v) 
Drug Particle size 
(µm) 
Drug 
Entrapment 
Shape 
MBD 5 3 3 10 173.9±2.3 83.2±3.3 Spherical 
MBD 6 3 4 10 168.4±4.5 84.3±1.8 Spherical 
MBD 7 3 5 10 163.7±2.7 86.4±2.5 Spherical 
MBD 8 3 6 10 158.2±3.3 89.5±2.8 Irregular 
 (n=3)  
Optimization of drug concentration  
Microbeads were optimized on the basis of average particle 
size, drug entrapment efficiency and their shape and surface 
morphology. The entrapment efficiency of drug depends on 
concentration of drug used. Entrapment efficiency was 
optimized by taking different concentration of drug and the 
other parameter was kept constant. 
  
Table 3: Optimization of drug concentration in the microbeads formulation 
Formulation 
Code 
Sodium 
Alginate 
(%w/v) 
Calcium 
Chloride 
(%) 
Drug 
Particle size 
(µm) 
Drug 
Entrapment 
MBD 9 3 4 10 160.7±3.1 88.9±2.1 
MBD 10 3 4 20 162.4±2.2 91.6±1.3 
MBD 11 3 4 30 163.5±2.6 94.6±2.6 
MBD 12 3 4 40 164.3±2.5 94.3±3.4 
 (n=3)  
Dubey et al                                                                                                           Journal of Drug Delivery & Therapeutics. 2019; 9(2-s):271-275 
ISSN: 2250-1177                                                                                  [273]                                                                                 CODEN (USA): JDDTAO 
Method of Characterization of Microbeads   
Particle size, polydispersity index and zeta potential   
Average particle size of microbeads was determined by 
optical microscopy. The microbeads were suspended in 
methanol and then dispersed on the glass slide. Slide was 
observed under microscope to determine the size of beads 
using ocular micrometer. More than 150 beads were 
observed for their size and the size was presented as their 
average. Measurement of surface charge was based on the 
zeta potential (e) that was calculated according to 
Helmholtz–Smoluchowsky from their electrophoretic 
mobility. For measurement of surface charge, zetasizer with 
a field strength of 20 V/cm on a large bore measures cell was 
used and samples were analyse after diluted with 0.9 % NaCl 
to adjust a conductivity of 50 lS/cm.  
 Particle shape and surface morphology  
Scanning Electron Microscopy (SEM) was used to examine 
surface morphology of microbeads. Samples were prepared 
by sprinkling lyophilized microbeads on double adhesive 
tape adhere on aluminum stub. Then gold coating (thickness 
about 300A°) was carried out using a sputter coater. Samples 
were examined and photomicrographs were taken under 
scanning electron microscope (LEO 435 VP, Eindhoven, 
Netherlands) at an acceleration voltage of 30 kV   SEM image 
performed at the Indian Institute of Science Education and 
Research (IISER), BHOPAL, MP, India.  
Entrapment efficiency  
Entrapment efficiency of microbeads for clonidine was 
determined according to the method described by Fry 
(1978)14 taking drug loaded microbeads equivalent to 100 
mg of clonidnesulphate with 5.0 mL of phosphate buffer pH 
7.4 in a beaker. The microbeads were kept for swell and 
allow for macerates for 24 hr then they were triturate with 
the help of pestle and morter. The mixture was centrifuged 
at 4000 rpm for 30 min to settle down the polymeric 
material and allow the drug in supernatant solution. The 1.0 
ml of sample from supernatant solution was taken in a 
volumetric flask and diluted upto 10 ml. The sample was 
analyzed for drug concentration using UV 
spectrophotometer.  
 
In vitro drug release  
The drug release was performed in PBS (pH 7.4) for 
clonidine loaded microbeads using dialysis bag technique. In 
this study microbeads equivalent to 100 mg of drug was 
taken in dialysis tubing (MWCO, 15 KDa, Himedia) and 
placed in a beaker containing 100 ml of PBS pH 7.4.  The 
dialysis bag retains microbeads and allows passing of free 
drug into the dissolution media. Temperature was 
maintained at 37 ± 1⁰ C throughout the study. 2 ml of 
samples were withdrawn after specified time intervals i.e. 
0.5, 1, 2, 3, 4, 5, 6, 8, 12, 24 and 48 h and replaced with the 
same volume of fresh PBS pH 7.4 and analyzed for drug 
concentration by using UV spectrophotometer.  
RESULT AND DISCUSSION  
Procured drug was odorless and white crystalline in nature. 
In solubility study it was found that drug was soluble in 
water, ethanol, methanol and slightly soluble in chloroform 
and phosphate buffer pH 7.4 and sparingly soluble in 0.1 N 
NaOH and 0.1N HCl. Melting point of drug was found 128ºC-
134ºC while it was 130 ºC reported in standard monograph. 
The partition coefficient (log p) value was found to be 1.59 
and 1.57 in n-Octanol:PBS pH 7.4 and n-Octanol:0.1 N HCl 
respectively. The obtained FT-IR characteristic peaks of drug 
was matched with the peaks of drug given in standard 
monograph was revealed similar.  The drug solution was 
scan on UV-spectrophotometer at 200-400 nm in web length 
range to determine the maximum absorbance (λ max) and it 
was found at 270 nm. The calibration curve was prepared in 
phosphate buffer pH 7.4 and distilled water. The regression 
coefficient (R2) was 0.999 which was shows the linearity of 
curve in both distilled water and phosphate buffer pH 7.4. 
The line of equation for the standard curve was y = 0.0139x + 
0.0038 and y = 0.0069x+0.0023. The drug excipient 
interaction study was performed to check in interaction 
between drug and other formulation excipients by 
spectrophotometricaly. There was no interaction was found 
between drug and excipients and it was clearly seen and 
confirmed by UV spectrophotometricaly scan graph of drug 
solution and mixture of drug and sodium alginate. All the 
data of preformulation study was found similar as given in 
standard monograph which confirmed that the drug was 
authenticate and pure in form and it could be used for 
formulation development of clonidine hydrochloride loaded 
microbeads. Clonidine hydrochloride loaded sodium alginate 
beads were successfully prepared by ionic gelation method. 
The microbeads formulations were optimized on the basis of 
average particle size, drug entrapment, shape and surface 
morphology. The mean diameter of optimized microbeads of 
Sodium alginate increased from 156.7±2.30 µm to 215.3±5.8 
µm with increasing polymer concentration from 1.0 to 4.0 % 
w/v. In the present investigation a 3.0 % w/v Sodium 
alginate concentration was found to be optimized which 
provide the required size of microbeads Fig. 1 and 2.   
 
Figure 1: Effect of polymer concentration on entrapment 
efficiency of microbeads 
 
Figure 2: Effect of polymer concentration on average 
particle size of microbeads 
The average particle size of microbeads increased with 
increasing polymer concentration, since at higher 
concentrations the polymer solution dispersed into larger 
droplets due to increasing the viscosity of polymer solution 
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and it was the reason behind the enhancement of average 
particle size of microbeads. In the case of entrapment 
efficiency, it was found increase on increasing the sodium 
alginate concentration it was due to the increasing the 
entrapment of drug molecules in the molecules of polymer 
and high dense or high concentration of polymer have more 
number of polymer molecule network to trap the drug 
molecules. In the case of optimization of calcium chloride 
concentration. The particles size found slightly decrease with 
increasing the calcium chloride concentration. Optimum 
concentration of calcium chloride is requiring creating 
complete gelation by ionic interaction of sodium alginate in 
the microbeads. The complete gelation is directly 
proportional to high stability and structural integrity for 
microbeads. There was no major difference was found in 
case of increasing drug concentration in the formulation but 
as increase the drug concentration from 10 to 30 %, the drug 
entrapment efficiency was found increase from 88.9±2.1 to 
95.6±2.6% Fig 3 and 4.   
 
Figure 3: Effect of calcium chloride on entrapment 
efficiency of microbeads 
 
Figure 4: Effect of calcium chloride on average particle 
size of microbeads 
Further increasing of drug concentration from 30 to 40 was 
not found any significant difference in drug entrapment 
efficiency. Formulation coding with MBD 11 consist of 3.0% 
w/v sodium alginate, 4.0% w/v calcium chloride and 30 % 
w/v drug concentration was selected as optimized 
formulation that was shown 94.3±3.4% drug entrapment 
and163.5±2.6 µm in average particle size Fig 5 and 6. 
 
Figure 5: Effect of drug concentration on entrapment 
efficiency of microbeads 
 
Figure 6: Effect of drug concentration on average 
particle size of microbeads 
Scanning electron microscopy (SEM) analysis revealed that 
the optimized microbeads formulation MBD 11 was found 
spherical in shape and smooth in surface Fig. 7. 
 
Figure 7: SEM photomicrograph of drug loaded sodium 
alginate beads 
In vitro drug release profile of clonidine hydrochloride in 
PBS pH 7.4 was found 83.46% after 48 hr Table 4 and Fig 8 
for optimized formulation (MBD-11) and follows the matrix 
diffuasion Higuchi release kinetics.   
Table 4: In-vitro drug release of clonidine hydrochloride 
in phosphate buffer pH 7.4 
S. No. Time 
interval (h) 
Plain drug Clonidine HCL 
Microbeads 
1 0.5 36.59 08.43 
2 1 49.15 16.53 
3 2 72.79 28.26 
4 3 91.38 35.68 
5 4 98.49 46.35 
6 5  54.23 
7 6  62.45 
8 8  69.38 
9 12  74.43 
10 24  79.34 
11 48  83.46 
 
 
Figure 8: In-vitro drug release of clonidine 
hydrochloride from microbeads 
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CONCLUSION 
It was concluded that from this study that the microbeads 
can be prepared from sodium alginate by ionic gelation 
method and can be encapsulate clonidine hydrochloride 
without any interaction.  It can release drug in very 
controlled and sustained manner following matrix diffusion 
Higuchi release kinetic model. The prepared microbeads 
were optimized for different formulation and process 
variables and found that microbeads was uniform, spherical 
and acceptable size range with high drug encapsulation 
efficiency.  The prepared formulation can be use to deliver 
drugs by oral route for it sustained delivery in GIT system 
and for maintaining its therapeutic concentration in blood 
for longer period of time and can be use for the effective 
management of anxiety and hypertensive disorder. 
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